Checkpoint inhibitors for the treatment of metastatic gastric cancers

Researchers evaluate early-phase and late-phase trials of immunotherapy in advanced gastric cancer. Read the full article in Cancer Treatment Reviews, Evolution of checkpoint inhibitors for the treatment of metastatic gastric cancers: Current status and future perspectives, linked below.